Scimitar Inc. published a piece detailing how founders and boards can make this strategic shift regarding IPO readiness.

Founded in 2007, Scimitar sought to fill a void in the life sciences industries. Scimitar founders realized that life sciences companies were relatively early in their operational maturity when compared to long established product development, manufacturing, and supply chain industries such as automotive or consumer goods. Scimitar Inc. brings best practices and innovative solutions to life sciences organizations via cutting-edge consulting in a collaborative effort to increase client profits and reinvestment in life-saving research, ultimately to improve well-being of patients everywhere. From research through commercial, Scimitar drives operational transformations and strategic initiatives across the drug product lifecycle. Our expertise is multi-dimensional: Strategy Development Strategy Realization Program Management Strategic Sourcing Governance Organizational Design Post-Merger Integration Risk Management Change Management Performance Measurement Scimitar serves our industry-leading clients by providing only experienced, capable consultants, who have demonstrated success across a large number of client engagements. Scimitar is unique relative to other consulting firms in that we… §…focus exclusively on clients, not internal projects and marketing efforts §…work together with your people, not around, behind, or above them §…do not rely on client projects to “train” our consultants §…do not operate under a pyramid structure, sparing you expensive partner premiums